Last updated on December 9th, 2025 at 12:42 pm
| Check Integris Medtech DRHP filing with SEBI. | Check Integris Medtech IPO allotment |
Integris Medtech Limited is a diversified medical-technology (MedTech) company engaged in the development, manufacturing, and distribution of cardiovascular devices and laboratory solutions.
It provides products like drug-eluting stents, diagnostic equipment, laboratory instruments, reagents, and consumables to hospitals and laboratories across India and global markets.
Integris Medtech is raising money via IPO out of which Fresh Issue is ~ ₹ 925 crore & Offer for Sale of up to 21,674,531 equity shares.
Subscription date to apply for Medtech is yet to be announced. Price band for the IPO is also pending to be declared.
Revenue, PAT, EBITDA of Integris Medtech Limited
| Year | Fiscal 2025 |
| Networth | ~ ₹ 2752.52 Cr |
| Revenue: | ~ ₹ 1902.46 Cr |
| EBITDA | ~ ₹ 309.39 Cr |
| PAT | ~ ₹ 70.68 Cr |
| EBITDA Margin: | ~16.26% |
| PAT Margin | ~3.72% |
Integris Medtech Limited Financials (Consolidated Figures)
| Year (Approx Values) | Revenue (₹ Cr) | Profit (₹ Cr) | Assets (₹ Cr) | Net Worth (₹ Cr) |
| 2023 | ₹ 1,348.1 | ~ ₹ -40.5 | ₹ 2,553.9 | ₹ 2,629.5 |
| 2024 | ₹ 1,553.4 | ~₹ -4.9 | ₹ 2,989.2 | ₹ 2,681.0 |
| 2025 | ₹ 1,902.5 | ₹ 70.7 | ₹ 3,641.3 | ₹ 2,752.5 |
Integris Medtech Limited IPO Grey market premium today
| Date | IPO Price | IPO GMP | GMP Trend | Estimated listing | Estimated profit per lot |
| 11-Dec | ₹ TBA | ₹ NA | – | ₹ – | ₹ – |
| 10-Dec | ₹ TBA | ₹ NA | – | ₹ – | ₹ – |
| 09-Dec | ₹ TBA | ₹ NA | – | ₹ – | ₹ – |
| 08-Dec | ₹ TBA | ₹ NA | – | ₹ – | ₹ – |
| 07-Dec | ₹ TBA | ₹ NA | – | ₹ – | ₹ – |
Integris Medtech Limited IPO Pros & Cons
Strengths:
- Diversified portfolio across stents, cardiac devices, and laboratory solutions reduces revenue concentration risks.
- Strong presence in cardiovascular devices with ~22% DES (Drug Eluting Stent) market share, offering steady industry demand.
- Global footprint with sales across 65+ countries ensures broader market reach and scalability.
- Turned profitable in FY25 with improving financial metrics, indicating strengthening operations.
- IPO funds will reduce subsidiary debt, improving balance-sheet health and future growth capacity.
Risks:
- Heavy reliance on regulatory approvals and compliance in multiple global markets increases operational risk.
- Business acquired through many acquisitions may face integration challenges and higher costs.
- Competitive MedTech industry with strong global players may slice margins.
- Revenue depends significantly on hospitals and labs, which fluctuate with healthcare spending cycles.
- Previous year losses highlight potential volatility in performance and execution risks.
Integris Medtech Limited: IPO date & invest detail
| IPO Open Date: | TBA |
| IPO Close Date: | TBA |
| Anchor Investor Bidding | TBA |
| IPO Allotment Date: | TBA |
| Refunds & Demat Credit | TBA |
| Tentative Listing Date: | TBA |
| IPO Category | Mainboard |
| Symbol | |
| Face Value: | Rs. 01 per Equity Share |
| Issue Size: | ₹ 925 crore + OFS of up to 21,674,531 equity shares |
| Lot Size: | TBA |
Integris Medtech Limited IPO Composition & Proceeds
| Fresh Issue: | ~ ₹ 925 crore |
| Offer for Sale: | ~ 21,674,531 equity shares |
| Employee reservation | – |
| Price Range | TBA |
| Use of Proceeds: | |
| Borrowing payment | ~ ₹ 696.39 Cr |
| Wholly owned Subsidiaries | ~ ₹ 125.39 Cr |
| Step-down Subsidiaries | ~ ₹ 570.99 Cr |
| General Corporate Purpose | Balance |
| IPO Listing on: | BSE – NSE |
| Retail Quota: | ≤ 10% |
| QIB Quota: | ≥ 75% |
| NII Quota: | ≤ 15% |
Integris Medtech Limited Lot Size details
| Application Type | Lot Size | No. of Lots | No. of Shares | Investment Amount |
| Retail(Min) | – | 1 | – | ₹ – |
| Retail (Max) | – | 13 | – | ₹ – |
| Small HNI (Min) | – | 14 | – | ₹ – |
| Small HNI (Max) | – | 66 | – | ₹ – |
| Big HNI (Min) | – | 67 | – | ₹ – |
Core Offerings of Integris Medtech Limited
Medtech’s core business includes cardiovascular devices like drug-eluting stents, drug-coated balloons, vascular-access solutions along with laboratory solutions like clinical diagnostics, life-science & industrial labs equipment/consumables and calibration services.
Integris Medtech Limited Promoters – Pre offer equity (Approx)
| Evercure Holdings Pte. Ltd | – |
| Medicore Holdings Pte. Ltd | – |
| Gurmit Singh Chugh | – |
| Punita Sharma | – |
Lead Managers / Registrars of Integris Medtech Limited
| Lead / Book Running Lead Managers | ICICI Securities, Axis Capital, Citigroup Global Markets India, IIFL Capital Services |
| Registrar (RTA) | KFin Technologies Limited |
Founding Year of Integris Medtech Limited & Managing Director
Integris Medtech Limited was incorporated on 25 April 2008.
Current CEO of Integris Medtech Limited is Mr. Probir Das.
Integris Medtech Limited FAQ
Q1. What is the business of Integris Medtech Limited?
Integris Medtech is a medical-technology company having diverse portfolio like manufacturing and selling cardiovascular devices like stents, balloons, vascular access tools and laboratory solutions.
Q2. Why is the company raising funds via IPO?
The proceeds from the IPO will be used mainly to repay certain borrowings taken by its wholly-owned and step-down subsidiaries, and for general corporate purposes.
Q3. What is the size of the issue and where will it list?
The issue size comprises a fresh issue of ₹ 925 crore and OFS for ~ 2.167 crore equity shares and it will be listed on the BSE NSE platform.
Q4. What are the risks to an investor?
Risks include regulatory and compliance requirements for medical-device firms, global competition in MedTech, execution/integration risks.
Q5. What are the potential upsides?
Potential upsides include growth in global and domestic healthcare demand, diversified product portfolio (cardio + laboratory), improving recent profitability, and the use IPO funds to reduce debt helping strengthen financials and growth potential.
Q6. How to apply for the IPO?
You can apply Via your brokerage/demat account or bank’s IPO/ASBA platform once the subscription window opens.
Q 7. When is the tentative listing date?
Expected listing date is is yet to be announced.
For more amazing blogs click here (IPO Corner).
Click for the latest upcoming IPO Calendar
For further information you can visit official website of Integris Medtech Limited
